ACHE and Alzheimer disease: Moreover, AD is a multi-pathogenic illness; therefore, the recent strategy in drug discovery is to synthesize novel and potent anti-Alzheimer agents with significant inhibition potential for acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes [3].